Skip to main content

Medications for Skin and Structure Infection

The medications listed below are related to or used in the treatment of this condition.

Filter
Drug name Rating Reviews Activity ? Rx/OTC Pregnancy CSA Alcohol
ampicillin / sulbactam Rate Add review
Rx B N
Generic name:
ampicillin / sulbactam systemic
Brand name:
Unasyn
Drug class:
beta-lactamase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Avelox I.V. Rate Add review
Rx C N
Generic name:
moxifloxacin systemic
Drug class:
quinolones and fluoroquinolones
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
aztreonam Rate Add review
Rx B N
Generic name:
aztreonam systemic
Brand name:
Azactam
Drug class:
miscellaneous antibiotics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Baxdela 10 1 review for Baxdela to treat Skin and Structure Infection
Rx N
Generic name:
delafloxacin systemic
Drug class:
quinolones and fluoroquinolones
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
cefaclor Rate Add review
Rx B N
Generic name:
cefaclor systemic
Drug class:
second generation cephalosporins
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
ceftaroline Rate Add review
Rx B N
Generic name:
ceftaroline systemic
Brand name:
Teflaro
Drug class:
next generation cephalosporins
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Centany AT Rate Add review
Rx B N
Generic name:
mupirocin topical
For consumers:
dosage, side effects
For professionals:
Prescribing Information
cilastatin / imipenem 10 1 review for cilastatin / imipenem to treat Skin and Structure Infection
Rx C N
Generic name:
cilastatin / imipenem systemic
Brand name:
Primaxin IV
Drug class:
carbapenems
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Cubicin RF Rate Add review
Rx B N
Generic name:
daptomycin systemic
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
dalbavancin 1.0 1 review for dalbavancin to treat Skin and Structure Infection
Rx C N
Generic name:
dalbavancin systemic
Brand name:
Dalvance
Drug class:
glycopeptide antibiotics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Dapzura RT Rate Add review
Rx B N
Generic name:
daptomycin systemic
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
delafloxacin 10 1 review for delafloxacin to treat Skin and Structure Infection
Rx N
Generic name:
delafloxacin systemic
Brand name:
Baxdela
Drug class:
quinolones and fluoroquinolones
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
dicloxacillin Rate Add review
Rx B N
Generic name:
dicloxacillin systemic
Drug class:
penicillinase resistant penicillins
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
Kimyrsa Rate Add review
Rx C N
Generic name:
oritavancin systemic
Drug class:
glycopeptide antibiotics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
nafcillin Rate Add review
Rx B N
Generic name:
nafcillin systemic
Drug class:
penicillinase resistant penicillins
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph, Prescribing Information
omadacycline Rate Add review
Rx N
Generic name:
omadacycline systemic
Brand name:
Nuzyra
Drug class:
tetracyclines
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Orbactiv 1.0 2 reviews for Orbactiv to treat Skin and Structure Infection
Rx C N
Generic name:
oritavancin systemic
Drug class:
glycopeptide antibiotics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
oritavancin 1.0 2 reviews for oritavancin to treat Skin and Structure Infection
Rx C N
Generic name:
oritavancin systemic
Brand names:
Kimyrsa, Orbactiv
Drug class:
glycopeptide antibiotics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Pirnuo Rate Add review
Rx B N
Generic name:
mupirocin topical
For consumers:
dosage, side effects
For professionals:
Prescribing Information
Primaxin IV Rate Add review
Rx C N
Generic name:
cilastatin / imipenem systemic
Drug class:
carbapenems
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Sivextro Rate Add review
Rx C N
Generic name:
tedizolid systemic
Drug class:
oxazolidinone antibiotics
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
Tazicef Rate Add review
Rx B N
Generic name:
ceftazidime systemic
Drug class:
third generation cephalosporins
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information
tedizolid Rate Add review
Rx C N
Generic name:
tedizolid systemic
Brand name:
Sivextro
Drug class:
oxazolidinone antibiotics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
telavancin Rate Add review
Rx C N
Generic name:
telavancin systemic
Brand name:
Vibativ
Drug class:
glycopeptide antibiotics
For consumers:
dosage, interactions, side effects
For professionals:
AHFS DI Monograph
Unasyn Rate Add review
Rx B N
Generic name:
ampicillin / sulbactam systemic
Drug class:
beta-lactamase inhibitors
For consumers:
dosage, interactions, side effects
For professionals:
Prescribing Information

Frequently asked questions

View more FAQ

Topics under Skin and Structure Infection

Alternative treatments for Skin and Structure Infection

The following products are considered to be alternative treatments or natural remedies for Skin and Structure Infection. Their efficacy may not have been scientifically tested to the same degree as the drugs listed in the table above. However, there may be historical, cultural or anecdotal evidence linking their use to the treatment of Skin and Structure Infection.

Learn more about Skin and Structure Infection

Legend

Rating For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective).
Activity Activity is based on recent site visitor activity relative to other medications in the list.
Rx Prescription only.
OTC Over-the-counter.
Rx/OTC Prescription or Over-the-counter.
Off-label This medication may not be approved by the FDA for the treatment of this condition.
EUA An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives.
Expanded Access Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available.
Pregnancy Category
A Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.
C Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks.
X Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits.
N FDA has not classified the drug.
Controlled Substances Act (CSA) Schedule
M The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication.
U CSA Schedule is unknown.
N Is not subject to the Controlled Substances Act.
1 Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision.
2 Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence.
3 Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence.
4 Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5 Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4.
Alcohol
X Interacts with Alcohol.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer